000			02072 a2200589 4500
005			20250516185535.0
264		0	_c20140512
008			201405s 0 0 eng d
022			_a2168-6084
024	7		_a10.1001/jamadermatol.2013.7919 _2doi
040			_aNLM _beng _cNLM
100	1		_aPark, June J
245	0	0	_aCutaneous granulomatous eruption and successful response to potent topical steroids in patients undergoing targeted BRAF inhibitor treatment for metastatic melanoma. _h[electronic resource]
260			_bJAMA dermatology _cMar 2014
300			_a307-11 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAdministration, Cutaneous
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aBiopsy, Needle
650	0	4	_aClobetasol _xtherapeutic use
650	0	4	_aDisease Progression
650	0	4	_aDrug Eruptions _xdrug therapy
650	0	4	_aFemale
650	0	4	_aFollow-Up Studies
650	0	4	_aHumans
650	0	4	_aImidazoles _xadverse effects
650	0	4	_aImmunohistochemistry
650	0	4	_aLower Extremity
650	0	4	_aMale
650	0	4	_aMelanoma _xpathology
650	0	4	_aMolecular Targeted Therapy _xmethods
650	0	4	_aNeoplasm Invasiveness _xpathology
650	0	4	_aNeoplasm Recurrence, Local _xdrug therapy
650	0	4	_aNeoplasm Staging
650	0	4	_aOximes _xadverse effects
650	0	4	_aProto-Oncogene Proteins B-raf _xadverse effects
650	0	4	_aPyridones _xadverse effects
650	0	4	_aPyrimidinones _xadverse effects
650	0	4	_aRisk Assessment
650	0	4	_aSampling Studies
650	0	4	_aSentinel Lymph Node Biopsy _xmethods
650	0	4	_aSkin Neoplasms _xpathology
650	0	4	_aSurvival Rate
650	0	4	_aTreatment Outcome
700	1		_aHawryluk, Elena B
700	1		_aTahan, Steven R
700	1		_aFlaherty, Keith
700	1		_aKim, Caroline C
773	0		_tJAMA dermatology _gvol. 150 _gno. 3 _gp. 307-11
856	4	0	_uhttps://doi.org/10.1001/jamadermatol.2013.7919 _zAvailable from publisher's website
999			_c23380521 _d23380521